Sophia Genetics Q3 2023 Gaap EPS $(0.21) Beats $(0.31) Estimate, Sales $16.30M Beat $15.63M Estimate
Portfolio Pulse from saritha@benzinga.com
Sophia Genetics (NASDAQ:SOPH) reported Q3 2023 GAAP EPS of $(0.21), beating the estimate of $(0.31) by 32.26%. The company also reported quarterly sales of $16.30M, surpassing the estimate of $15.63M by 4.31%. Both figures represent significant increases from the same period last year.
November 07, 2023 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sophia Genetics reported better than expected Q3 2023 results, with both EPS and sales beating estimates.
Sophia Genetics reported better than expected Q3 2023 results, with both EPS and sales beating estimates. This indicates strong performance and could lead to a positive market reaction, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100